Each fall, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes Master Symposium in Chicago to receive up-to-the-minute information on the latest developments affecting Hatch-Waxman litigation and participate in significant peer-to-peer networking opportunities. Goodwin's John Bennett will be speaking on a panel titled, Assessing the Latest Use of §101 Challenges to Method of Use Patents in a Paragraph IV Setting.
For more information, visit the event website.